Evolent Health (NYSE:EVH) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.10 by 40 percent. This is a 82.35 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $483.65 million which beat the analyst consensus estimate of $460.31 million by 5.07 percent. This is a 24.39 percent decrease over sales of $639.65 million the same period last year.